The effect of particle size on the cytotoxicity, inflammation, developmental toxicity and genotoxicity of silver nanoparticles

Biomaterials

Volumn 32, Issue 36, 2011, Pages 9810-9817

  Park, Margriet V D Z ^a,b   Neigh, Arianne M ^c   Vermeulen, Jolanda P ^b   de la Fonteyne, Liset J J ^b   Verharen, Henny W ^b   Briedé, Jacob J ^a   van Loveren, Henk ^a,b   de Jong, Wim H ^b  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^c NanoComposix Inc   (United States)

Author keywords

In vitro assays; Nanomaterials; Silver; Size related; Toxicity

Indexed keywords

ADVERSE EFFECT; ANTI-MICROBIAL AGENT; CELL DAMAGE; CELL TYPES; CYTOTOXIC; DEVELOPMENTAL TOXICITY; DIFFERENT SIZES; GENOTOXICITIES; IN-VITRO ASSAYS; MEDICAL DEVICES; MEMBRANE DAMAGE; METABOLIC ACTIVITY; SILVER IONS; SILVER NANOPARTICLES; SIZE-RELATED; WOUND DRESSINGS;

BIOMEDICAL ENGINEERING; CELL CULTURE; CYTOTOXICITY; METAL IONS; NANOPARTICLES; PATHOLOGY; TOXICITY;

SILVER;

SILVER; SILVER NANOPARTICLE;

ANIMAL CELL; ARTICLE; CELL DAMAGE; CELL METABOLISM; CELL STRAIN L 929; CONTROLLED STUDY; CYTOTOXICITY; DEVELOPMENTAL TOXICITY; EMBRYO; GENOTOXICITY; IN VITRO STUDY; INFLAMMATION; MACROPHAGE; MEMBRANE DAMAGE; MOUSE; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; TOXICITY;

ANIMALS; BIOLOGICAL MARKERS; CELL DEATH; CELL MEMBRANE; CELL PROLIFERATION; ELECTRON SPIN RESONANCE SPECTROSCOPY; EMBRYONIC DEVELOPMENT; EMBRYONIC STEM CELLS; EXTRACELLULAR SPACE; FIBROBLASTS; INFLAMMATION; L-LACTATE DEHYDROGENASE; LIGHT; MACROPHAGES; METAL NANOPARTICLES; MICE; MICE, INBRED C57BL; MUTAGENS; MUTATION; PARTICLE SIZE; REACTIVE OXYGEN SPECIES; SCATTERING, RADIATION; SILVER;

EID: 80054061986     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2011.08.085     Document Type: Article

References (43)

1. Wijnhoven S.W.P., Peijnenburg W.J.G.M., Herberts C.A., Hagens W.I., Oomen A.G., Heugens E.H.W., et al. Nano-silver - a review of available data and knowledge gaps in human and environmental risk assessment. Nanotoxicology 2009, 3(2):109-138.
2. Schrand A.M., Rahman M.F., Hussain S.M., Schlager J.J., Smith D.A., Syed A.F. Metal-based nanoparticles and their toxicity assessment. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2010, 2(5):544-568.
3. Christensen F.M., Johnston H.J., Stone V., Aitken R.J., Hankin S., Peters S., et al. Nano-silver - feasibility and challenges for human health risk assessment based on open literature. Nanotoxicology 2010, 4(3):284-295.
4. Lankveld D.P., Oomen A.G., Krystek P., Neigh A., Troost-de Jong A., Noorlander C.W., et al. The kinetics of the tissue distribution of silver nanoparticles of different sizes. Biomaterials 2010, 31(32):8350-8361.
5. Foldbjerg R., Olesen P., Hougaard M., Dang D.A., Hoffmann H.J., Autrup H. PVP-coated silver nanoparticles and silver ions induce reactive oxygen species, apoptosis and necrosis in THP-1 monocytes. Toxicol Lett 2009, 190(2):156-162.
6. Park E.J., Yi J., Kim Y., Choi K., Park K. Silver nanoparticles induce cytotoxicity by a Trojan-horse type mechanism. Toxicol In Vitro 2010, 24(3):872-878.
7. Shavandi Z., Ghazanfari T., Moghaddam K.N. In vitro toxicity of silver nanoparticles on murine peritoneal macrophages. Immunopharmacol Immunotoxicol 2011, 33(1):135-140.
8. Soto K., Garza K.M., Murr L.E. Cytotoxic effects of aggregated nanomaterials. Acta Biomater 2007, 3(3):351-358.
9. Nishanth R.P., Jyotsna R.G., Schlager J.J., Hussain S.M., Reddanna P. Inflammatory responses of RAW 264.7 macrophages upon exposure to nanoparticles: role of ROS-NFkappaB signaling pathway. Nanotoxicology 2011, 10.3109/17435390.2010.541604.
10. Piao M.J., Kang K.A., Lee I.K., Kim H.S., Kim S., Choi J.Y., et al. Silver nanoparticles induce oxidative cell damage in human liver cells through inhibition of reduced glutathione and induction of mitochondria-involved apoptosis. Toxicol Lett 2011, 201(1):92-100.
11. Carlson C., Hussain S.M., Schrand A.M., Braydich-Stolle L.K., Hess K.L., Jones R.L., et al. Unique cellular interaction of silver nanoparticles: size-dependent generation of reactive oxygen species. J Phys Chem B 2008, 112(43):13608-13619.
12. Braydich-Stolle L., Hussain S., Schlager J.J., Hofmann M.C. In vitro cytotoxicity of nanoparticles in mammalian germline stem cells. Toxicol Sci 2005, 88(2):412-419.
13. Ahamed M., Karns M., Goodson M., Rowe J., Hussain S.M., Schlager J.J., et al. DNA damage response to different surface chemistry of silver nanoparticles in mammalian cells. Toxicol Appl Pharmacol 2008, 233(3):404-410.
14. AshaRani P.V., Low Kah Mun G., Hande M.P., Valiyaveettil S. Cytotoxicity and genotoxicity of silver nanoparticles in human cells. ACS Nano 2009, 3(2):279-290.
15. Foldbjerg R., Dang D.A., Autrup H. Cytotoxicity and genotoxicity of silver nanoparticles in the human lung cancer cell line, A549. Arch Toxicol 2011, 85(7):743-750.
16. Hackenberg S., Scherzed A., Kessler M., Hummel S., Technau A., Froelich K., et al. Silver nanoparticles: evaluation of DNA damage, toxicity and functional impairment in human mesenchymal stem cells. Toxicol Lett 2011, 201(1):27-33.
17. Kawata K., Osawa M., Okabe S. In vitro toxicity of silver nanoparticles at noncytotoxic doses to HepG2 human hepatoma cells. Environ Sci Technol 2009, 43(15):6046-6051.
18. Bhol K.C., Schechter P.J. Effects of nanocrystalline silver (NPI 32101) in a rat model of ulcerative colitis. Dig Dis Sci 2007, 52(10):2732-2742.
19. Shin S.H., Ye M.K., Kim H.S., Kang H.S. The effects of nano-silver on the proliferation and cytokine expression by peripheral blood mononuclear cells. Int Immunopharmacol 2007, 7(13):1813-1818.
20. Tian J., Wong K.K., Ho C.M., Lok C.N., Yu W.Y., Che C.M., et al. Topical delivery of silver nanoparticles promotes wound healing. ChemMedChem 2007, 2(1):129-136.
21. Wong K.K., Cheung S.O., Huang L., Niu J., Tao C., Ho C.M., et al. Further evidence of the anti-inflammatory effects of silver nanoparticles. ChemMedChem 2009, 4(7):1129-1135.
22. Trickler W.J., Lantz S.M., Murdock R.C., Schrand A.M., Robinson B.L., Newport G.D., et al. Silver nanoparticle induced blood-brain barrier inflammation and increased permeability in primary rat brain microvessel endothelial cells. Toxicol Sci 2010, 118(1):160-170.
23. Lee K.J., Nallathamby P.D., Browning L.M., Osgood C.J., Xu X.H. In vivo imaging of transport and biocompatibility of single silver nanoparticles in early development of zebrafish embryos. ACS Nano 2007, 1(2):133-143.
24. Asharani P.V., Lianwu Y., Gong Z., Valiyaveettil S. Comparison of the toxicity of silver, gold and platinum nanoparticles in developing zebrafish embryos. Nanotoxicology 2011, 5(1):43-54.
25. Bar-Ilan O., Albrecht R.M., Fako V.E., Furgeson D.Y. Toxicity assessments of multisized gold and silver nanoparticles in zebrafish embryos. Small 2009, 5(16):1897-1910.
26. Li P.W., Kuo T.H., Chang J.H., Yeh J.M., Chan W.H. Induction of cytotoxicity and apoptosis in mouse blastocysts by silver nanoparticles. Toxicol Lett 2010, 197(2):82-87.
27. Mahabir A.G., Zwart E., Schaap M., van Benthem J., de Vries A., Hernandez L.G., et al. LacZ mouse embryonic fibroblasts detect both clastogens and mutagens. Mutat Res 2009, 666(1-2):50-56.
28. Park M.V.D.Z., Annema W., Salvati A., Lesniak A., Elsaesser A., Barnes C., et al. In vitro developmental toxicity test detects inhibition of stem cell differentiation by silica nanoparticles. Toxicol Appl Pharmacol 2009, 240:108-116.
29. Park M.V.D.Z., Verharen H.W., Zwart E., Hernandez L.G., van Benthem J., Elsaesser A., et al. Genotoxicity evaluation of amorphous silica nanoparticles of different sizes using the micronucleus and the plasmid lacZ gene mutation assay. Nanotoxicology 2011, 5:168-181.
30. Park M.V.D.Z., Lankveld D.P.K., van Loveren H., de Jong W. The status of in vitro toxicity studies in risk assessment of nanomaterials. Nanomedicine 2009, 4(6):669-685.
31. Stone V., Johnston H., Schins R.P. Development of in vitro systems for nanotoxicology: methodological considerations. Crit Rev Toxicol 2009, 39(7):613-626.
32. van Maanen J.M., Borm P.J., Knaapen A., van Herwijnen M., Schilderman P.A., Smith K.R., et al. In vitro effects of coal fly ashes: hydroxyl radical generation, iron release, and DNA damage and toxicity in rat lung epithelial cells. Inhal Toxicol 1999, 11(12):1123-1141.
33. Slob W. Dose-response modeling of continuous endpoints. Toxicol Sci 2002, 66(2):298-312.
34. Rivm PROAST: software for dose-response modeling and benchmark dose analysis 2009, Available from:. http://www.proast.nl.
35. EFSA Guidance of the Scientific Committee on a request from EFSA on the use of the benchmark dose approach in risk assessment. EFSA J 2009, 1150:1-72.
36. Nel A., Xia T., Madler L., Li N. Toxic potential of materials at the nanolevel. Science 2006, 311(5761):622-627.
37. Xia T., Kovochich M., Brant J., Hotze M., Sempf J., Oberley T., et al. Comparison of the abilities of ambient and manufactured nanoparticles to induce cellular toxicity according to an oxidative stress paradigm. Nano Lett 2006, 6(8):1794-1807.
38. Parameswaran N., Patial S. Tumor necrosis factor-alpha signaling in macrophages. Crit Rev Eukaryot Gene Expr 2010, 20(2):87-103.
39. Driscoll K.E. Macrophage inflammatory proteins: biology and role in pulmonary inflammation. Exp Lung Res 1994, 20(6):473-490.
40. Steward W.P. Granulocyte and granulocyte-macrophage colony-stimulating factors. Lancet 1993, 342(8864):153-157.
41. Chang C. The immune effects of naturally occurring and synthetic nanoparticles. J Autoimmun 2010, 34(3):J234-J246.
42. Liu W., Wu Y., Wang C., Li H.C., Wang T., Liao C.Y., et al. Impact of silver nanoparticles on human cells: effect of particle size. Nanotoxicology 2010, 4(3):319-330.
43. Demir E., Vales G., Kaya B., Creus A., Marcos R. Genotoxic analysis of silver nanoparticles in Drosophila. Nanotoxicology 2011, 5:417-424.